Meta-analysis of superficial versus deep injection of radioactive tracer and blue dye for lymphatic mapping and detection of sentinel lymph nodes in breast cancer

British Journal of Surgery

Volumn 102, Issue 3, 2015, Pages

  Ahmed, M ^a   Purushotham, A D ^a,b   Horgan, K ^c   Klaase, J M ^d   Douek, M ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d MEDISCH SPECTRUM TWENTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COLORING AGENT; RADIOISOTOPE; TRACER;

BREAST NEOPLASMS; COHORT ANALYSIS; DIAGNOSTIC USE; EVALUATION STUDY; FEMALE; HUMAN; IMAGE GUIDED BIOPSY; INJECTION; LYMPH NODE; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; META ANALYSIS; PATHOLOGY; PEROPERATIVE CARE; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENTINEL LYMPH NODE BIOPSY; TREATMENT OUTCOME;

BREAST NEOPLASMS; COHORT STUDIES; COLORING AGENTS; FEMALE; HUMANS; IMAGE-GUIDED BIOPSY; INJECTIONS; INTRAOPERATIVE CARE; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHOSCINTIGRAPHY; RADIOACTIVE TRACERS; RADIOISOTOPES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SENTINEL LYMPH NODE BIOPSY; TREATMENT OUTCOME;

EID: 84923022296     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.9673     Document Type: Review

References (42)

1. Giuliano AE, Kirgan DM, Guenther JM, Morton DL,. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994; 220: 391-398.
2. Krag DN, Weaver DL, Alex JC, Fairbank JT,. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993; 2: 335-339.
3. Kim T, Giuliano AE, Lyman GH,. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer 2006; 106: 4-16.
4. Gill G,; SNAC Trial Group of the Royal Australasian College of Surgeons (RACS) and NHMRC Clinical Trials Centre. Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): a randomized controlled surgical trial. Ann Surg Oncol 2009; 16: 266-275.
5. Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Ashikaga T, et al,.; National Surgical Adjuvant Breast and Bowel Project. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 2007; 8: 881-888.
6. Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM, et al,. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 2006; 98: 599-609.
7. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, et al,. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003; 349: 546-553.
8. Zavagno G, De Salvo GL, Scalco G, Bozza F, Barutta L, Del Bianco P, et al,.; GIVOM Trialists. A randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial. Ann Surg 2008; 247: 207-213.
9. Peres J., Use of sentinel node biopsy expands. J Natl Cancer Inst 2013; 105: 1423-1424.
10. Lyman GH, Giuliano AE, Somerfield MR, Benson AB III, Bodurka DC, Burstein HJ, et al,.; American Society of Clinical Oncology. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005; 23: 7703-7720.
11. Sappey MPC,. Anatomie, Physiologie, Pathologie des Vaisseaux Lymphatiques Consideres Chez l'Homme et les Vertebres., A. Delehaye, and, E. Lacrosnier,: Paris, 1874.
12. Cserni G, Szekeres JP,. Internal mammary lymph nodes and sentinel node biopsy in breast cancer. Surg Oncol 2001; 10: 25-33.
13. Uren RF, Howman-Giles R, Chung DK, Spillane AJ, Noushi F, Gillett D, et al,. SPECT/CT scans allow precise anatomical location of sentinel lymph nodes in breast cancer and redefine lymphatic drainage from the breast to the axilla. Breast 2012; 21: 480-486.
14. Bauer TW, Spitz FR, Callans LS, Alavi A, Mick R, Weinstein SP, et al,. Subareolar and peritumoral injection identify similar sentinel nodes for breast cancer. Ann Surg Oncol 2002; 9: 169-176.
15. Fowler JC, Solanki CK, Guenther I, Barber R, Miller F, Bobrow L, et al,. A pilot study of dual-isotope lymphoscintigraphy for breast sentinel node biopsy comparing intradermal and intraparenchymal injection. Eur J Surg Oncol 2009; 35: 1041-1047.
16. Noushi F, Spillane AJ, Uren RF, Cooper R, Allwright S, Snook KL, et al,. High discordance rates between sub-areolar and peri-tumoural breast lymphoscintigraphy. Eur J Surg Oncol 2013; 39: 1053-1060.
17. Roumen RM, Geuskens LM, Valkenburg JG,. In search of the true sentinel node by different injection techniques in breast cancer patients. Eur J Surg Oncol 1999; 25: 347-351.
18. The Nordic Cochrane Centre. Review Manager (RevMan) [computer program], version 5.0. The Nordic Cochrane Centre: Copenhagen, 2008.
19. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, et al,.; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370: 1453-1457.
20. Demets DL,. Methods for combining randomized clinical trials: strengths and limitations. Stat Med 1987; 6: 341-350.
21. Higgins JPT, Green S, (eds). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 (updated February 2008). http://handbook.cochrane.org/v5.0.0/ [accessed 21 October 2014].
22. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
23. Higgins JP, Thompson SG,. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558.
24. Caruso G, Cipolla C, Costa R, Morabito A, Latteri S, Fricano S, et al,. Lymphoscintigraphy with peritumoral injection versus lymphoscintigraphy with subdermal periareolar injection of technetium-labeled human albumin to identify sentinel lymph nodes in breast cancer patients. Acta Radiol 2014; 55: 39-44.
25. De Cicco C, Trifiro G, Intra M, Marotta G, Ciprian A, Frasson A,. Optimised nuclear medicine method for tumour marking and sentinel node detection in occult primary breast lesions. Eur J Nucl Med Mol Imaging 2004; 31: 349-354.
26. Eroglu A, Mudun A, Berberoglu K, Asoglu O, Ozmen V, Muslumanoglu M, et al,. Comparison of subdermal and peritumoral injection techniques of lymphoscintigraphy to determine the sentinel lymph node in breast cancer. Clin Nucl Med 2004; 29: 306-311.
27. Gray RJ, Pockaj BA,. A concordance study of subareolar and subdermal injections for breast cancer sentinel lymph node mapping. Am J Surg 2004; 188: 423-425.
28. Johnson CB, Boneti C, Korourian S, Adkins L, Klimberg VS,. Intraoperative injection of subareolar or dermal radioisotope results in predictable identification of sentinel lymph nodes in breast cancer. Ann Surg 2011; 254: 612-618.
29. Kaklamanos IG, Birbas K, Syrigos K, Bonatsos VG, Bonatsos G,. Prospective comparison of peritumoral and subareolar injection of blue dye alone, for identification of sentinel lymph nodes in patients with early stage breast cancer. J Surg Oncol 2011; 104: 37-40.
30. Mateos JJ, Vidal-Sicart S, Zanón G, Pahisa J, Fuster D, Martin F, et al,. Sentinel lymph node biopsy in breast cancer patients: subdermal versus peritumoural radiocolloid injection. Nucl Med Comm 2001; 22: 17-24.
31. Maza S, Valencia R, Geworski L, Zander A, Guski H, Winzer KJ, Munz DL,. Peritumoural versus subareolar administration of technetium-99m nanocolloid for sentinel lymph node detection in breast cancer: preliminary results of a prospective intra-individual comparative study. Eur J Nucl Med Mol Imaging 2003; 30: 651-656.
32. Mudun A, Sanli Y, Ozmen V, Turkmen C, Ozel S, Eroglu A, et al,. Comparison of different injection sites of radionuclide for sentinel lymph node detection in breast cancer: single institution experience. Clin Nucl Med 2008; 33: 262-267.
33. Pelosi E, Baiocco C, Ala A, Gay E, Bello M, Varetto T, et al,. Lymphatic mapping in early stage breast cancer: comparison between periareolar and subdermal injection. Nucl Med Commun 2003; 24: 519-523.
34. Pelosi E, Bello M, Giors M, Ala A, Giani R, Bussone R, et al,. Sentinel lymph node detection in patients with early-stage breast cancer: comparison of periareolar and subdermal/peritumoral injection techniques. J Nucl Med 2004; 45: 220-225.
35. Rodier JF, Velten M, Wilt M, Martel P, Ferron G, Vaini-Elies V, et al,. Prospective multicentric randomized study comparing periareolar and peritumoral injection of radiotracer and blue dye for the detection of sentinel lymph node in breast sparing procedures: FRANSENODE trial. J Clin Oncol 2007; 25: 3664-3669.
36. Shimazu K, Tamaki Y, Taguchi T, Takamura Y, Noguchi S,. Comparison between periareolar and peritumoral injection of radiotracer for sentinel lymph node biopsy in patients with breast cancer. Surgery 2002; 131: 277-286.
37. Suami H, Pan WR, Mann GB, Taylor GI,. The lymphatic anatomy of the breast and its implications for sentinel lymph node biopsy: a human cadaver study. Ann Surg Oncol 2008; 15: 863-871.
38. Fabry HF, Mutsaers PG, Meijer S, Torrenga H, Pijpers R, Van Leeuwen PA, et al,. Clinical relevance of parasternal uptake in sentinel node procedure for breast cancer. J Surg Oncol 2004; 87: 13-18.
39. Mansel RE, Goyal A, Newcombe RG,; ALMANAC Trialists Group. Internal mammary node drainage and its role in sentinel lymph node biopsy: the initial ALMANAC experience. Clin Breast Cancer 2004; 5: 279-284.
40. Kong AL, Tereffe W, Hunt KK, Yi M, Kang T, Weatherspoon K, et al,. Impact of internal mammary lymph node drainage identified by preoperative lymphoscintigraphy on outcomes in patients with stage I to III breast cancer. Cancer 2012; 118: 6287-6296.
41. Veronesi U, Cascinelli N, Greco M, Bufalino R, Morabito A, Galluzzo D, et al,. Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Ann Surg 1985; 202: 702-707.
42. Veronesi U, Marubini E, Mariani L, Valagussa P, Zucali R,. The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomised trial. Eur J Cancer 1999; 35: 1320-1325.